Prevalence and impact of pain in diabetic neuropathy

European Diabetes Nursing

Volumn 6, Issue 2, 2009, Pages 58-64

  Geerts, M ^a   Bours, G J J W ^b,c   de Wit, R ^c   Landewe S A N T ^a   van Haarlem, A ^a   Schaper, N C ^a,c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ZUYD UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Anxiety; Depression; Diabetic neuropathy; Pain interference; Pain severity

Indexed keywords

EID: 70350443013     PISSN: 15517853     EISSN: 15517861     Source Type: Journal    
DOI: 10.1002/edn.136     Document Type: Article

References (32)

1. Jude E, Boulton AJM. End stage complications of diabetic neuropathy. Diab Rev 1999; 7: 395-410.
2. Jude EB, Schaper NC. Treating painful diabetic polyneuropathy. BMJ 2007; 335: 57-58.
3. Meyer-Rosberg K, Kvarnstrom A, Kinnman E, et al. Peripheral neuropathic pain: a multidimensional burden for patients. Eur J Pain 2001; 5: 379-389.
4. Chan AW, MacFarlane IA, Bowsher DR, et al. Chronic pain in patients with diabetes mellitus: comparison with non-diabetic population. The Pain Clinic 1990; 3: 147-159.
5. Ziegler D, Gries AF, Spuler M, et al. The epidemiology of diabetic neuropathy. J Diabetes Complicat 1992; 6: 49-57.
6. Daousi C, MacFarlane IA, Woodward A, et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 2004; 21: 976-982.
7. Benbow SJ, Wallymahmed ME, MacFarlane A. Diabetic peripheral neuropathy and quality of life. Q J Med 1998; 91: 733-737.
8. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000; 47: 123-128.
9. Low P, Dotson R. Symptom treatment of painful neuropathy. JAMA 1998; 280: 1863-1864.
10. Barbano RL, Herrmann DN, Hart-Gouleau S, et al. Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol 2004; 61: 914-918.
11. Polydefkis M, Hauer P, Sheth S, et al. The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain 2004; 127: 1606-1615.
12. Valk GD, de Sonaville JJ, van Houtum WH, et al. The assessment of diabetic polyneuropathy in daily clinical practice: reproducibility and validity of Semmes Weinstein monofilaments examination and clinical neurological examination. Muscle Nerve 1997; 20: 116-118.
13. Zelman DC, Gore M, Dukes E, et al. Validation of a modified version of the Brief Pain Inventory for painful diabetic peripheral neuropathy. J Pain Symptom Manage 2005; 29: 401-410.
14. Keller S, Bann CM, Dodd SL, et al. Validity of the Brief Pain Inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain 2004; 20: 309-318.
15. Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, mechanisms and treatment recommendations. Arch Neurol 2003; 60: 1524-1534.
16. Dworkin R, Nagasako E, Galer B. Assessment of neuropathic pain. Handbook of Pain Assessment. New York: Guilford Press, 2002; 519-548.
17. Health Science Program RAND 36-item Health Survey i.o. Santa Monica, CA: RAND, 1992. www.rand.org/pubs/reprints/RP247/ [accessed 17 July 2009].
18. Clouet F, Excler-Cavailher G, Christophe B, et al. Type 2 diabetes and short form 36-items health survey. Diabetes Metab 2001; 27: 711-717.
19. van der Zee KI, Sanderman R. Het meten van de algemene gezondheidstoestand met de RAND-36: een handleiding. Groningen: Noordelijk Centrum voor Gezondheidsvraagstukken, 1993; 9-14 (in Dutch).
20. Bjelland I, Dahl A, Haug T, et al. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 52: 69-77.
21. Johnston M, Pollard B, Hennessey P. Construct validation of the Hospital Anxiety and Depression Scale with clinical populations. J Psychosom Res 2000; 48: 579-584.
22. Spinhoven P, Ormel J, Sloekers P, et al. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychological Med 1997; 27: 363-370.
23. Croon EM de, Nieuwenhuijsen K, Hugenholtz NIR, et al. Drie vragenlijsten voor diagnostiek van depressie en angststoornissen. TBV 2005; 13: 98-103 (in Dutch).
24. Gore M, Brandenburg NA, Hoffman DL, et al. Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives. J Pain 2006; 7: 892-900.
25. Toelle T, Xu X, Sadosky AB. Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns. J Diabetes Complicat 2006; 20: 26-33.
26. Wit R de, Dam F van, Loonstraa S, et al. The Amsterdam Pain Management Index compared to eight frequently used outcome measures to evaluate the adequacy of pain treatment in cancer patients with chronic pain. Pain 2001; 91: 339-349.
27. Gore M, Brandenburg N, Dukes E, et al. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression and sleep. J Pain Symptom Manage 2005; 30: 374-385.
28. Currie CJ, Poole CD, Woehl A, et al. The health-related utility and health-related quality of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy. Diabetologia 2006; 49: 2272-2280.
29. Vileikyte L, Leventhal H, Gonzalez JS, et al. Diabetic peripheral neuropathy and depressive symptoms: the association revisited. Diabetes Care 2005; 28: 2378-2383.
30. Andreassen CS, Jakobsen J, Andersen H. Muscle weakness: a progressive late complication in diabetic distal symmetric polyneuropathy. Diabetes 2006; 55: 806-812.
31. Jensen TS, Backonja MM, Hernández Jiménez S, et al. New perspectives on the management of diabetic peripheral neuropathic pain. Diabetes Vasc Dis Res 2006; 3: 108-119.
32. Sorensen L, Molyneaux L, Yue DK. The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care 2006; 29: 883-887.